| 1 |
Design, synthesis and biological evaluation of novel 1,5-disubstituted isatin derivatives as antitumor agents |
|
|
| Huijun Zhuo,Zhen Zhang,Yang Liu,Jingya Zhang,Guisen Zhao |
|
| Medicinal Chemistry Research. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity |
|
|
| Rui Guo,Yinan Hua,Jun Ren,Karin E. Bornfeldt,Sreejayan Nair |
|
| Cell Death & Disease. 2018; 9(6) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Proapoptotic effect and the mechanism of action of pingyangmycin on cavernous hemangiomas |
|
|
| YIDENG HUANG,PING LI,SIWEN XIA,YANG ZHUO,LONGJUN WU |
|
| Experimental and Therapeutic Medicine. 2014; 7(2): 473 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Effect of Lentinan in Induction of Apoptosis on Gastric Adenocarcinoma Cells |
|
|
| Reza Najafipour,Taghi Naserpour Farivar,Pouran Johari |
|
| Biotechnology and Health Sciences. 2014; 1(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Trop2 and its overexpression in cancers: regulation and clinical/ therapeutic implications |
|
|
| Anna Shvartsur,Benjamin Bonavida |
|
| Genes & Cancer. 2014; 6(3-4): 84 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Chemotherapy agents induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway |
|
|
| Xi Wang,Min Long,Ke Dong,Fang Lin,Yuanyuan Weng,Yongri Ouyang,Li Liu,Junxia Wei,Xi Chen,Ting He,Hui-Zhong Zhang |
|
| Cancer Biology & Therapy. 2013; 14(12) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Nanomedicine strategies for drug delivery to the ear |
|
|
| Christian Oliver Pritz,József Dudás,Helge Rask-Andersen,Anneliese Schrott-Fischer,Rudolf Glueckert |
|
| Nanomedicine. 2013; 8(7): 1155 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Overexpression of TROP2 Predicts Poor Prognosis of Patients with Cervical Cancer and Promotes the Proliferation and Invasion of Cervical Cancer Cells by Regulating ERK Signaling Pathway |
|
|
| Ting Liu,Yueyang Liu,Xiangxiang Bao,Jiguang Tian,Yang Liu,Xingsheng Yang,Irina U. Agoulnik |
|
| PLoS ONE. 2013; 8(9): e75864 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Nanomedicine strategies for drug delivery to the ear |
|
|
| Pritz, C.O. and Dudás, J. and Rask-Andersen, H. and Schrott-Fischer, A. and Glueckert, R. |
|
| Nanomedicine. 2013; 8(7): 1155-1172 |
|
| [Pubmed] [Google Scholar] |
|
